Liver Cancer Research
At Fred Hutch, our liver cancer researchers create new models of the disease in order to better understand the genetic changes that drive it. They pinpoint the biomarkers that will improve detection. And they test drug therapies to improve outcomes for patients.
ON THIS PAGE
Researchers and Patient Treatment | Clinical Trials | Liver Cancer Research
Our Liver Cancer Researchers
Our interdisciplinary scientists and clinicians work together to prevent, diagnose and treat liver cancer as well as other cancers and diseases.
Patient Treatment and Care
At Fred Hutch, our interdisciplinary teams work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our aim is to provide patients access to advanced treatment options while getting the best cancer care.
Selected Liver Cancer Clinical Trials
Clinical research is an essential part of the scientific process that leads to new treatments and better care. Clinical trials can also be a way for patients to get early access to new
cutting-edge therapies. Our clinical research teams are running clinical studies on various kinds of liver cancer.
Liver Cancer Research
Our researchers study the molecular mechanisms behind liver tumor formation and the factors that affect liver cancer development. They aim to use these findings to advance early detection and diagnosis. Our scientists also study the factors that affect whether a particular treatment works for a given patient. Our clinical trials test new and experimental drug therapies.
Earlier Detection
HCC is the third most common cause of cancer-related death. High mortality rates stem in part from the difficulty of detecting HCC in its early stages. Our researchers are developing better ways to identify liver cancer earlier when it is easier to treat.
Hepatitis B and C
The hepatitis B and C viruses can cause liver cancer. Because infection is common, liver cancer will remain a major public health threat. Fred Hutch researchers are studying several aspects of hepatitis B and C viruses, with the aim of preventing liver cancer. For example, they are studying how the viruses are transmitted and how they affect cancer patients with compromised immune systems. Our researchers are also developing new techniques to cure hepatitis infection using gene-editing techniques.
New Drug Targets
The hepatitis B and C viruses can cause liver cancer. Because infection is common, liver cancer will remain a major public health threat. Fred Hutch researchers are studying several aspects of hepatitis B and C viruses, with the aim of preventing liver cancer. For example, they are studying how the viruses are transmitted and how they affect cancer patients with compromised immune systems. Our researchers are also developing new techniques to cure hepatitis infection using gene-editing techniques.
Earlier Detection
HCC is the third-most common cause of cancer-related death. High mortality rates stem in part from the difficulty of detecting HCC in its early stages. Hutch researchers are developing better ways to identify liver cancer earlier, when it is easier to treat.
New Drug Targets
Decoding the molecular mechanisms of cancer cells, and how they go off track, can help researchers discover new drug targets. Hutch scientists work to pinpoint the critical genetic changes that promote liver cancer and learn how it so successfully evades surveillance. Their goal: translate discoveries into new therapeutic avenues for patients.
Hepatitis B and Hepatitis C
The hepatitis B and C viruses cause liver cancer. Because infection is common, liver cancer will remain a major public health threat. Fred Hutch researchers are studying several aspects of hepatitis B and C viruses, with the aim of preventing liver cancer. For example, they are studying how the viruses are transmitted and how they affect cancer patients with compromised immune systems. Hutch researchers are also developing new techniques to cure hepatitis infection using gene-editing techniques.